Tech Company Financing Transactions

Qu Biologics Funding Round

Qu Biologics, operating out of Burnaby BC, secured $2.5 million from private investors.

Transaction Overview

Company Name
Announced On
12/31/2015
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
This latest round allows Qu to expand its clinical footprint by initiating a randomized, controlled clinical trial in one or more cancer indications in 2016.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4475 Wayburne Dr. 305
Burnaby BC, V5G 4X4
Canada
Email Address
Not Recorded
Overview
Qu Biologics is developing a platform of new immunotherapeutic treatments. Our Site Specific Immunomodulators (SSIs) aim to activate the body's immune system to reverse the chronic inflammation underlying many conditions including cancer and immune-related diseases, such as Crohn's disease.
Profile
Qu Biologics LinkedIn Company Profile
Social Media
Qu Biologics Company Twitter Account
Company News
Qu Biologics News
Facebook
Qu Biologics on Facebook
YouTube
Qu Biologics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Hal Gunn
  Hal Gunn LinkedIn Profile  Hal Gunn Twitter Account  Hal Gunn News  Hal Gunn on Facebook
Chief Medical Officer
Simon Sutcliffe
  Simon Sutcliffe LinkedIn Profile  Simon Sutcliffe Twitter Account  Simon Sutcliffe News  Simon Sutcliffe on Facebook
VP - Finance
Nicole Clendinning
  Nicole Clendinning LinkedIn Profile  Nicole Clendinning Twitter Account  Nicole Clendinning News  Nicole Clendinning on Facebook
VP - Manufacturing
Alun Rees
  Alun Rees LinkedIn Profile  Alun Rees Twitter Account  Alun Rees News  Alun Rees on Facebook
VP - Operations
James Pankovich
  James Pankovich LinkedIn Profile  James Pankovich Twitter Account  James Pankovich News  James Pankovich on Facebook
VP - Operations
Gillian Vandermeirsch
  Gillian Vandermeirsch LinkedIn Profile  Gillian Vandermeirsch Twitter Account  Gillian Vandermeirsch News  Gillian Vandermeirsch on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2015: 915 Labs venture capital transaction
Next: 12/31/2015: Ender Labs venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary